Literature DB >> 23604357

Mutant Cu,Zn superoxide dismutase in motor neuron disease.

M E Gurney, R Liu, J S Althaus, E D Hall, D A Becker.   

Abstract

Cu,Zn superoxide dismutase (Cu,Zn SOD) is one of several anti-oxidant enzymes which defend the cell against damage by oxygen free radicals. Mutations of the SOD1 gene encoding Cu,Zn SOD are found familial amyotrophic lateral sclerosis, a progressive and fatal paralytic disease which is caused by the death of motor neurons in cortex, brainstem and spinal cord. The disease can be reproduced in transgenic mice by expression of mutant human Cu,Zn SOD. Recent studies both in vitro and in vivo suggest that the effect of mutation is to enhance the generation of oxygen radicals by the mutant enzyme. Thus, mutation converts a protective, antioxidant enzyme into a destructive pro-oxidant form which catalyzes free radical damage to which motor neurons are uniquely vulnerable.

Entities:  

Year:  1998        PMID: 23604357      PMCID: PMC3455714          DOI: 10.1007/s11357-998-0012-x

Source DB:  PubMed          Journal:  Age (Omaha)        ISSN: 0161-9152


  24 in total

1.  Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I.

Authors:  L T KURLAND; D W MULDER
Journal:  Neurology       Date:  1955-03       Impact factor: 9.910

2.  Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide.

Authors:  M B Yim; P B Chock; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis.

Authors:  M C Dal Canto; M E Gurney
Journal:  Acta Neuropathol       Date:  1997-06       Impact factor: 17.088

4.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

5.  Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis.

Authors:  M Wiedau-Pazos; J J Goto; S Rabizadeh; E B Gralla; J A Roe; M K Lee; J S Valentine; D E Bredesen
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

6.  Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  A Y Chiu; P Zhai; M C Dal Canto; T M Peters; Y W Kwon; S M Prattis; M E Gurney
Journal:  Mol Cell Neurosci       Date:  1995-08       Impact factor: 4.314

7.  Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.

Authors:  M C Dal Canto; M E Gurney
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.